Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer

Clinical Endocrinology

Volumn 58, Issue 4, 2003, Pages 513-518

  Lin, Shih Yi ^a,b   Wang, Ya Y ^a   Sheu, Wayne H H ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOITER; HUMAN; MALE; MEDICAL SOCIETY; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THYROID DISEASE; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, PAPILLARY; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037381995     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01749.x     Document Type: Article

References (25)

1. Brierley, J.D., Panzarella, T., Tsang, R.W., Gospodarowicz, M.K. & O'Sullivan, B. (1997) A comparison of different staging systems predictability of patient outcome. Cancer, 79, 2414-2423.
2. Bunone, G., Vigneri, P., Mariani, L., Buto, S., Collini, P., Pilotti, S., Pierotti, M.A. & Bongarzone, I. (1999) Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. American Journal of Pathology, 155, 1967-1976.
3. Chambers, A.F. & Matrisian, L.M. (1997) Changing views of the role of matrix metalloproteinase in metastasis. Journal of National Cancer Institute, 89, 126-1270.
4. DeGroot, L.J., Kaplan, E.L., McCromick, M. & Straus, F.H. (1990) Nature history, treatment, and course of papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 71, 414-424.
5. Folkman, J. (1995) Angiogenesis in cancer, vasculature, rheumatoid disease, and other diseases. Nature Medicine, 1, 27-31.
6. Gordon, M.S., Margolin, K., Talpaz, M., Sledge, G.W., Holmgren, E., Benjamin, R., Stalter, S., Shak, S. & Adelman, D. (2001) Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. Journal of Clinical Oncology, 19, 843-850.
7. Hanahan, D. & Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
8. Hofmann, A., Laue, S., Rost, A.K., Scherbaum, W.A. & Aust, G. (1998) mRNA levels of membrane-type 1 matrix metalloproteinase (MTI-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Thyroid, 8, 203-214.
9. Jelkmann, W. (2001) Pitfalls in the measurement of circulating vascular endothelial growth factor. Clinical Chemistry, 47, 617-623.
10. Jung, K., Lein, M., Laube, C. & Lichtinghagen, R. (2001) Blood specimen collection methods influence the concentration and validity of matrix metalloproteinase 9 in blood. Clinica Chimica Acta, 314, 241-244.
11. Klein, M., Vignaud, J.M., Hennequin, V., Toussaint, B., Bresler, L., Plenat, F., Leclere, J., Duprez, A. & Weryha, G. (2001) Increased expression of the vascular endothelial growth factor is a pejorative prognosis factor in papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 656-658.
12. Kraiem, Z. & Korem, S. (2000) Matrix metalloproteinases and the thyroid. Thyroid, 10, 1061-1069.
13. McCawley, L.J. & Matrisian, L.M. (2000) Matrix metalloproteinases: multifunctional contributors to tumor progression. Molecular Medicine Today, 6, 149-156.
14. Maeta, H., Ohgi, S. & Terada, T. (2001) Protein expression of matrix metelloproteinase 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas. Virchows Archiv, 438, 121-128.
15. Mazzaferri, E.L. & Jhiang, S.M. (1994) Loner-term impact of initial surgical, and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
16. Merchant, S.H., Izquierdo, R. & Khurana, K.K. (2000) Is repeated fine-needle aspiration cytology useful in the management of patients with benign nodular thyroid disease? Thyroid, 10, 489-492.
17. Nelson, A.R., Fingleton, B., Rothenberg, M.L. & Matrisian, L.M. (2000) Matrix metalloproteinase: biological activity and clinical implications. Journal of Clinical Oncology, 18, 1135-1149.
18. Poon, R.T.P., Fan, S.T. & Wong, J. (2001) Clinical implications of circulating angiogenic factors in cancer patients. Journal of Clinical Oncology, 19, 1207-1225.
19. Ramsden, J.D. (2000) Angiogenesis in the thyroid gland. Thyroid, 166, 475-480.
20. Sang, Q.X. (1998) Complex role of matrix metalloproteinases in angiogenesis. Cell Research, 8, 171-177.
21. Sato, K., Miyakawa, M., Onoda, N., Demura, H., Yamashita, H., Miura, M., Kasajima, T., Yamazaki, A. & Obara, T.M. (1997) Increased concentration of vascular growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules. Journal of Clinical Endocrinology and Metabolism, 82, 1968-1973.
22. Soh, E.Y., Sobhi, S.A., Wong, M.G., Meng, Y.J., Siperstein, A.E., Clark, O.H. & Duh, Q.Y. (1996) Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery, 120, 944-947.
23. Soh, E.Y., Duh, Q.Y., Sobhi, S.A., Young, D.M., Epstein, H.D., Wong, M.G., Garcia, Y.J., Min, Y.D., Grossman, R.F., Siperstein, A.E. & Clark, O.H. (1997) Vascular endothelial growth factor expression is higher than in differentiated thyroid cancer than in normal or benign thyroid. Journal of Clinical Endocrinology and Metabolism, 82, 3741-3747.
24. Zucker, S., Lysik, R.M., Dimassimo, B.I., Zarrabi, H.M., Moll, U.M., Grimson, R., Tickle, S.P. & Dochery, A.J. (1995) Plasma assay of gelatinases B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer, 76, 700-708.
25. Zucker, S., Hymowitz, M., Conner, C., Zarrabi, H.M., Hurewitz, A.N., Matrisian, L., Boyd, D., Nicolson, G. & Montana, S. (1999) Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Annals of the New York Academy of Sciences, 878, 212-217.